INVEX THERAPEUTICS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.078 AUD | -7.14% |
|
-2.50% | -3.70% |
| Mar. 20 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
| Feb. 16 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
Quotes 5-day view
Delayed Quote Australian S.E.| 2024-05-02 | 2024-05-06 | 2024-05-07 | 2024-05-08 | |
|---|---|---|---|---|
| Last | 0.08 $ | 0.086 $ | 0.084 $ | 0.078 $ |
| Volume | 6 987 | 73 199 | 17 121 | 26 900 |
| Change | -2.44% | +7.50% | -2.33% | -7.14% |
| Opening | 0.08 | 0.08 | 0.08 | 0.08 |
| High | 0.08 | 0.09 | 0.08 | 0.08 |
| Low | 0.08 | 0.07 | 0.08 | 0.08 |
Performance
| 1 day | -7.14% | ||
| 1 week | -2.50% | ||
| Current month | -2.50% | ||
| 1 month | -12.36% | ||
| 3 months | -4.88% | ||
| 6 months | -65.33% | ||
| Current year | -3.70% | ||
| 1 year | -81.43% | ||
| 3 years | -88.44% |
Volumes
marketsDaily volume
26 900
Estimated daily volume
26 900
Avg. Volume 20 sessions
45 036
Daily volume ratio
0.60
Avg. Volume 20 sessions AUD
3 512.81
Avg. Volume 20 sessions USD
2 318.80
Record volume 1
4 697 816
Record volume 2
4 610 995
Record volume 3
3 370 815
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
5 863 633
Capitalization (USD)
3 870 584
Net sales (AUD)
459 085
Net sales (USD)
303 042
Free-Float
40.21 %
Free-Float capitalization (AUD)
2 357 854
Free-Float capitalization (USD)
1 556 419
Average Daily Capital Traded
0.06%
Highs and lows
1 week
0.07
0.09
1 month
0.070.09
Current year
0.070.11
1 year
0.060.63
3 years
0.060.82
5 years
0.062.05
10 years
0.062.05
Indicators
Moving average 5 days
0.08
Moving average 20 days
0.08
Moving average 50 days
0.09
Moving average 100 days
0.08
Price spread / (MMA5)
+5.13%
Price spread / (MMA20)
+8.08%
Price spread / (MMA50)
+10.38%
Price spread / (MMA100)
+7.69%
STIM
RSI 9 days
38.20
RSI 14 days
41.11
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -7.14% | -2.50% | -3.70% | -81.43% | 3.87M | ||
| -4.39% | -6.15% | +17.96% | -10.33% | 44.96B | ||
| -0.04% | +1.27% | +48.77% | -7.00% | 41.85B | ||
| +2.13% | +4.79% | +1.17% | +24.46% | 42.65B | ||
| +1.69% | +2.88% | -4.27% | +12.28% | 29.04B | ||
| +0.11% | +2.06% | +11.42% | +64.37% | 26.08B | ||
| -0.59% | -1.22% | -21.39% | -28.68% | 19.03B | ||
| +1.71% | +4.68% | +4.86% | -0.36% | 12.75B | ||
| -2.26% | -0.61% | +27.29% | +85.66% | 12.06B | ||
| -0.86% | -2.29% | -3.50% | +22.45% | 11.75B | ||
| -0.67% | +0.71% | +20.18% | +24.51% | 11.72B | ||
| +0.07% | +1.47% | -2.60% | -7.09% | 9.67B | ||
| -1.51% | -0.46% | +15.68% | +97.85% | 6.68B | ||
| +2.65% | +3.80% | +28.31% | -10.27% | 6.9B | ||
| -0.10% | +0.98% | +8.59% | -30.93% | 6.7B | ||
| -0.53% | -7.34% | +29.88% | +48.23% | 6.15B | ||
| Average | -0.61% | -0.34% | +11.17% | +12.73% | ||
| Weighted average by Cap. | -0.30% | +0.26% | +13.08% | +13.74% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -3.70% | ||
| 2023 | -85.14% | ||
| 2022 | -22.70% | ||
| 2021 | -1.40% | ||
| 2020 | -16.86% | ||
| 2019 | -20.00% |
- Stock Market
- Equities
- IXC Stock
- Quotes Invex Therapeutics Ltd